Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Open-Label Trial to Determine the Safety of PEP on a Skin Graft Donor Site Wound

NCT04664738 is registered in ClinicalTrials.gov with Rion Inc. as lead sponsor.

NCT NCT04664738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Open-Label Trial to Determine the Safety of PEP on a Skin Graft Donor Site Wound
Lead sponsor
Rion Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
March 16, 2021
Completion date
February 2, 2024
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

skin graft